Yang/Qi invigoration: An herbal therapy for chronic fatigue syndrome with yang deficiency?

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Leong, Pou Kuan ^a   Wong, Hoi Shan ^a   Chen, Jihang ^a   Ko, Kam Ming ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT;

BIOCHEMISTRY; CHINESE MEDICINE; CHRONIC FATIGUE SYNDROME; CISTANCHE; ENERGY METABOLISM; HUMAN; MITOCHONDRION; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; REVIEW; WESTERN MEDICINE; YANG DEFICIENCY; YIN DEFICIENCY;

EID: 84924155939     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/945901     Document Type: Review

References (50)

1. Z. Zhen, Advanced Textbook on Traditional Chinese Medicine and Pharmacology, vol. 1, New World Press, Beijing, China, 1995.
2. H. Yin and X. Shuai, Fundamentals of Traditional Chinese Medicine, Foreign Languages Press, Beijing, China, 1992.
3. K. A. O'Brien and C. C. Xue, "The theoretical framework of Chinese medicine," in A Comprehensive Guide to Chinese Medicine, P. C. Leung, C. C. Xue, and Y. C. Chen, Eds., World Scientific Publishers, Singapore, 2003.
4. Z. Liu and L. Liu, Essentials of Chinese Medicine, Springer, London, UK, 2009.
5. D. Zhang and X. Wu, "Qi, blood, body fluid, essence of life and spirit," in The Basic Knowledge of Traditional Chinese Medicine, Y. Liu, Ed., vol. 5, chapter 5, Hai Feng Publishing, Hong Kong, 1991.
6. Å. B. Gustafsson and R. A. Gottlieb, "Heart mitochondria: gates of life and death," Cardiovascular Research, vol. 77, no. 2, pp. 334-343, 2008.
7. S. C. Hand and M. A. Menze, "Mitochondria in energy-limited states: mechanisms that blunt the signaling of cell death," The Journal of Experimental Biology, vol. 211, no. 12, pp. 1829-1840, 2008.
8. Y. Y. Wang, S. L. Chang, Y. E. Wu, T. L. Hsu, and W. K. Wang, "Resonance: the missing phenomenon in hemodynamics," Circulation Research, vol. 69, no. 1, pp. 246-249, 1991.
9. Y.-Y. L. Wang, T.-L. Hsu, M.-Y. Jan, and W.-K. Wang, "Review: theory and applications of the harmonic analysis of arterial pressure pulse waves," Journal of Medical and Biological Engineering, vol. 30, no. 3, pp. 125-131, 2010.
10. E. S. Cannizzo, C. C. Clement, R. Sahu, C. Follo, and L. Santambrogio, "Oxidative stress, inflamm-aging and immunosenescence," Journal of Proteomics, vol. 74, no. 11, pp. 2313-2323, 2011.
11. M. de La Fuente, A. Hernanz, and M. C. Vallejo, "The immune system in the oxidative stress conditions of aging and hypertension: favorable effects of antioxidants and physical exercise," Antioxidants & Redox Signaling, vol. 7, no. 9-10, pp. 1356-1366, 2005.
12. Y.-M. Yiu and M.-Y. Qiu, "A preliminary epidemiological study and discussion on traditional Chinese medicine pathogenesis of chronic fatigue syndrome in Hong Kong," Journal of Chinese integrative medicine., vol. 3, no. 5, pp. 359-362, 2005.
13. L. Wu and C. Yan, "Functions of visceral organs in energy metabolism and body temperature regulation in tradition Chinese medicine," Journal of Gansu College of Traditional Chinese Medicine, vol. 21, pp. 12-13, 2004 (Chinese).
14. L. Zhao, H. Wu, M. Qiu et al., "Metabolic signatures of kidney Yang deficiency syndrome and protective effects of two herbal extracts in rats using GC/TOF MS," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 540957, 10 pages, 2013.
15. X. Lu, Z. Xiong, J. Li, S. Zheng, T. Huo, and F. Li, "Metabonomic study on 'Kidney-Yang Deficiency syndrome' and intervention effects of Rhizoma Drynariae extracts in rats using ultra performance liquid chromatography coupled with mass spectrometry," Talanta, vol. 83, no. 3, pp. 700-708, 2011.
16. 1H NMRand pattern recognition," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 843048, 6 pages, 2012.
17. R. Chen, J. Moriya, J.-I. Yamakawa, T. Takahashi, and T. Kanda, "Traditional chinese medicine for chronic fatigue syndrome," Evidence-based Complementary and Alternative Medicine, vol. 7, no. 1, pp. 3-10, 2010.
18. N. Afari and D. Buchwald, "Chronic fatigue syndrome: a review," The American Journal of Psychiatry, vol. 160, no. 2, pp. 221-236, 2003.
19. E. W. Brenu, K. J. Ashton, G. M. Atkinson, D. R. Staines, and S. Marshall-Gradisnik, "Gene expression in chronic fatigue syndrome," in An International Perspective on the Future of Research in Chronic Fatigue Syndrome, C. R. Snell, Ed., InTech Open Access Publishing, Zagreb, Croatia, 2012.
20. A. V. Plioplys and S. Plioplys, "Electron-microscopic investigation of muscle mitochondria in chronic fatigue syndrome," Neuropsychobiology, vol. 32, no. 4, pp. 175-181, 1995.
21. S. Myhill, N. E. Booth, and J. McLaren-Howard, "Chronic fatigue syndrome and mitochondrial dysfunction," International Journal of Clinical and Experimental Medicine, vol. 2, no. 1, pp. 1-16, 2009.
22. D. E. J. Jones, K. G. Hollingsworth, R. Taylor, A. M. Blamire, and J. L. Newton, "Abnormalities in pH handling by peripheral muscle and potential regulation by the autonomic nervous system in chronic fatigue syndrome," Journal of Internal Medicine, vol. 267, no. 4, pp. 394-401, 2010.
23. D. E. J. Jones, K. G. Hollingsworth, D. G. Jakovljevic et al., "Loss of capacity to recover from acidosis on repeat exercise in chronic fatigue syndrome: a case-control study," European Journal of Clinical Investigation, vol. 42, no. 2, pp. 186-194, 2012.
24. V.B. Wyller, K. Godang, L.Mørkrid, J.P. Saul, E. Thaulow, and L. Walløe, "Abnormal thermoregulatory responses in adolescents with chronic fatigue syndrome: relation to clinical symptoms," Pediatrics, vol. 120, no. 1, pp. e129-e137, 2007.
25. D. L. Hamilos, D. Nutter, J. Gershtenson et al., "Core body temperature is normal in chronic fatigue syndrome," Biological Psychiatry, vol. 43, no. 4, pp. 293-302, 1998.
26. E. J. Price and P. J. W. Venables, "Dry eyes and mouth syndrome-a subgroup of patients presenting with sicca symptoms," Rheumatology, vol. 41, no. 4, pp. 416-422, 2002.
27. G. Morris, M. Berk, P. Galecki, and M. Maes, "The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs)," Molecular Neurobiology, vol. 49, no. 2, pp. 741-756, 2014.
28. M. B. Van Elzakker, "Chronic fatigue syndrome from vagus nerve infection: a psychoneuroimmunological hypothesis," Medical Hypotheses, vol. 81, no. 3, pp. 414-423, 2013.
29. T. D. Jeppesen, M. Schwartz, D. B. Olsen et al., "Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy," Brain: A Journal of Neurology, vol. 129, no. 12, pp. 3402-3412, 2006.
30. D. van Cauwenbergh, M. de Kooning, K. Ickmans, and J. Nijs, "How to exercise people with chronic fatigue syndrome: evidence-based practice guidelines," European Journal of Clinical Investigation, vol. 42, no. 10, pp. 1136-1144, 2012.
31. D. Chambers, A.-M. Bagnall, S. Hempel, and C. Forbes, "Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review," Journal of the Royal Society of Medicine, vol. 99, no. 10, pp. 506-520, 2006.
32. P. Whiting, A.-M. Bagnall, A. J. Sowden, J. E. Cornell, C. D. Mulrow, and G. Ramírez, "Interventions for the treatment and management of chronic fatigue syndrome: a systematic review," Journal of the American Medical Association, vol. 286, no. 11, pp. 1360-1368, 2001.
33. T. Kindlon, "Reporting of harms associated with graded exercise therapy and cognitive behavioural therapy in myalgic encephalomyelitis/chronic fatigue syndrome," Bulletin of the IACFS/ME, vol. 19, pp. 59-111, 2011.
34. K.-M. Ko, T. Y. Y. Leon, D. H. F. Mak, P.-Y. Chiu, Y. Du, and M. K. T. Poon, "A characteristic pharmacological action of 'Yang-invigorating' Chinese tonifying herbs: enhancement of myocardial ATP-generation capacity," Phytomedicine, vol. 13, no. 9-10, pp. 636-642, 2006.
35. K. M. Ko and H. Y. Leung, "Enhancement of ATP generation capacity, antioxidant activity and immunomodulatory activities by Chinese Yang and Yin tonifying herbs," Chinese Medicine, vol. 2, article 3, 2007.
36. P. K. Leong, N. Chen, and K. M. Ko, "Mitochondrial decay in ageing: 'Qi-invigorating' schisandrin B as a hormetic agent for mitigating age-related diseases," Clinical and Experimental Pharmacology and Physiology, vol. 39, no. 3, pp. 256-264, 2012.
37. H. S. Wong and K.M. Ko, "Herba Cistanches stimulates cellular glutathione redox cycling by reactive oxygen species generated frommitochondrial respiration in H9c2 cardiomyocytes," Pharmaceutical Biology, vol. 51, no. 1, pp. 64-73, 2013.
38. W. Bains, "Treating chronic fatigue states as a disease of the regulation of energy metabolism," Medical Hypotheses, vol. 71, no. 4, pp. 481-488, 2008.
39. H. Zong, J. M. Ren, L. H. Young et al., "AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 25, pp. 15983-15987, 2002.
40. D. Kukidome, T. Nishikawa, K. Sonoda et al., "Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells," Diabetes, vol. 55, no. 1, pp. 120-127, 2006.
41. K.-M. Ko and P.-Y. Chiu, "Biochemical basis of the "Qiinvigorating" action of Schisandra berry (Wu-Wei-Zi) in Chinese medicine," The American Journal of Chinese Medicine, vol. 34, no. 2, pp. 171-176, 2006.
42. Y. Chen, J. Tang, X. Wang, F. Sun, and S. Liang, "An immunostimulatory polysaccharide (SCP-IIa) from the fruit of Schisandra chinensis (Turcz.) Baill," International Journal of Biological Macromolecules, vol. 50, no. 3, pp. 844-848, 2012.
43. T. Zhao, G. Mao, R. Mao et al., "Antitumor and immunomodulatory activity of a water-soluble low molecular weight polysaccharide from Schisandra chinensis (Turcz.) Baill," Food and Chemical Toxicology, vol. 55, pp. 609-616, 2013.
44. R. Checker, R. S. Patwardhan, D. Sharma et al., "Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-κB," Free Radical Biology and Medicine, vol. 53, no. 7, pp. 1421-1430, 2012.
45. P. Y. Lam, P. K. Leong, N. Chen, and K. M. Ko, "Schisandrin B enhances the glutathione redox cycling and protects against oxidant injury in different types of cultured cells," BioFactors, vol. 37, no. 6, pp. 439-446, 2011.
46. P. Y. Chiu, H. Y. Leung, M. K. T. Poon, and K. M. Ko, "Chronic schisandrin B treatment improves mitochondrial antioxidant status and tissue heat shock protein production in various tissues of young adult and middle-aged rats," Biogerontology, vol. 7, no. 4, pp. 199-210, 2006.
47. P. K. Leong, P. Y. Chiu, N. Chen, H. Y. Leung, and K. M. Ko, "Schisandrin B elicits a glutathione antioxidant response and protects against apoptosis via the redox-sensitive ERK/Nrf2 pathway in AML12 hepatocytes," Free Radical Research, vol. 45, pp. 483-495, 2011.
48. C.-H. Wang, S.-B. Wu, Y.-T. Wu, and Y.-H. Wei, "Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging," Experimental Biology and Medicine, vol. 238, no. 5, pp. 450-460, 2013.
49. K. M. Ko, N. Chen, H. Y. Leung, E. P. K. Leong, M. K. T. Poon, and P. Y. Chiu, "Long-term schisandrin B treatment mitigates age-related impairments in mitochondrial antioxidant status and functional ability in various tissues, and improves the survival of aging C57BL/6J mice," Biofactors, vol. 34, no. 4, pp. 331-342, 2008.
50. K. M. Holmstrom, L. Baird, Y. Zhang et al., "Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration," Biology Open, vol. 2, no. 8, pp. 761-770, 2013.